Urinary ethyl glucuronide (uEtG) accurately detects alcohol consumption in liver transplant candidates and recipients, researchers have confirmed. The study suggests that a combination of uEtG and the Alcohol Use Disorders Identification Test for alcohol consumption (AUDIT-c) are best in alerting doctors to alcohol consumption by patients undergoing evaluation for liver transplantation or who have received liver transplants.